Drug class
Short-acting beta-2 adrenergic receptor agonist; bronchodilator
Mechanism of action
Activates beta-2 adrenergic receptors on bronchial smooth muscle, increases intracellular cyclic AMP and produces bronchodilation. At higher systemic exposure, beta-adrenergic effects may also influence cardiac rate and contractility.
General use cases
- Relief of reversible bronchospasm in asthma and other obstructive airway diseases in countries where fenoterol inhalers remain authorised
- Some formulations have historically been used for obstetric tocolysis; route-specific indications must not be transferred to inhaled products
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
